These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24434818)

  • 1. Analysis of an asymmetric two-strain dengue model.
    Kooi BW; Aguiar M; Stollenwerk N
    Math Biosci; 2014 Feb; 248():128-39. PubMed ID: 24434818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level.
    Gulbudak H; Browne CJ
    J Math Biol; 2020 May; 80(6):1803-1843. PubMed ID: 32157381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Framework for Inferring Unobserved Multistrain Epidemic Subpopulations Using Synchronization Dynamics.
    Forgoston E; Shaw LB; Schwartz IB
    Bull Math Biol; 2015 Jul; 77(7):1437-55. PubMed ID: 26251155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of seasonality and import in a minimalistic multi-strain dengue model capturing differences between primary and secondary infections: complex dynamics and its implications for data analysis.
    Aguiar M; Ballesteros S; Kooi BW; Stollenwerk N
    J Theor Biol; 2011 Nov; 289():181-96. PubMed ID: 21907213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antibody-dependent enhancement, cross immunity, and vector population on the dynamics of dengue fever.
    Hu K; Thoens C; Bianco S; Edlund S; Davis M; Douglas J; Kaufman JH
    J Theor Biol; 2013 Feb; 319():62-74. PubMed ID: 23206388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinations in disease models with antibody-dependent enhancement.
    Billings L; Fiorillo A; Schwartz IB
    Math Biosci; 2008 Feb; 211(2):265-81. PubMed ID: 17923138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex behaviour in a dengue model with a seasonally varying vector population.
    McLennan-Smith TA; Mercer GN
    Math Biosci; 2014 Feb; 248():22-30. PubMed ID: 24291301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive exclusion in a vector-host model for the dengue fever.
    Feng Z; Velasco-Hernández JX
    J Math Biol; 1997 May; 35(5):523-44. PubMed ID: 9145954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coinfection, Altered Vector Infectivity, and Antibody-Dependent Enhancement: The Dengue-Zika Interplay.
    Olawoyin O; Kribs C
    Bull Math Biol; 2020 Jan; 82(1):13. PubMed ID: 31933003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial cross-enhancement in models for dengue epidemiology.
    Woodall H; Adams B
    J Theor Biol; 2014 Jun; 351():67-73. PubMed ID: 24568780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection risk to travelers going to dengue fever endemic regions.
    Pongsumpun P; Patanarapelert K; Sriprom M; Varamit S; Tang IM
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):155-9. PubMed ID: 15272760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling original antigenic sin in dengue viral infection.
    Nikin-Beers R; Ciupe SM
    Math Med Biol; 2018 Jun; 35(2):257-272. PubMed ID: 28339786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stochastic dynamics of dengue epidemics.
    de Souza DR; Tomé T; Pinho ST; Barreto FR; de Oliveira MJ
    Phys Rev E Stat Nonlin Soft Matter Phys; 2013 Jan; 87(1):012709. PubMed ID: 23410361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical models for dengue fever epidemiology: A 10-year systematic review.
    Aguiar M; Anam V; Blyuss KB; Estadilla CDS; Guerrero BV; Knopoff D; Kooi BW; Srivastav AK; Steindorf V; Stollenwerk N
    Phys Life Rev; 2022 Mar; 40():65-92. PubMed ID: 35219611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
    Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
    Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross immunity protection and antibody-dependent enhancement in a distributed delay dynamic model.
    Steindorf V; Oliva S; Wu J
    Math Biosci Eng; 2022 Jan; 19(3):2950-2984. PubMed ID: 35240815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.
    Flipse J; Wilschut J; Smit JM
    Traffic; 2013 Jan; 14(1):25-35. PubMed ID: 22998156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the relationship between antibody-dependent enhancement and immunological distance with application to dengue.
    Adams B; Boots M
    J Theor Biol; 2006 Sep; 242(2):337-46. PubMed ID: 16631802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexity of host-vector dynamics in a two-strain dengue model.
    Rashkov P; Kooi BW
    J Biol Dyn; 2021 Dec; 15(1):35-72. PubMed ID: 33357025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.